RAD 2.78% 3.5¢ radiopharm theranostics limited

Ann: Radiopharm Receives Strategic Investment for up to A$18 mill, page-8

  1. 1,447 Posts.
    lightbulb Created with Sketch. 486
    One of the assets that Lantheus has taken was LRRC15 antibody for osteosarcoma (aggressive bone cancer).

    It has both ODD and RPDD from the FDA.

    I hope we don't regret selling it cheap.
 
watchlist Created with Sketch. Add RAD (ASX) to my watchlist
(20min delay)
Last
3.5¢
Change
-0.001(2.78%)
Mkt cap ! $37.01M
Open High Low Value Volume
3.6¢ 3.7¢ 3.5¢ $70.43K 1.973M

Buyers (Bids)

No. Vol. Price($)
5 647890 3.5¢
 

Sellers (Offers)

Price($) Vol. No.
3.7¢ 300000 1
View Market Depth
Last trade - 15.28pm 26/07/2024 (20 minute delay) ?
RAD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.